Doxorubicin and β-lapachone release and interaction with micellar core materials: Experiment and modeling

Experimental Biology and Medicine

Volumn 232, Issue 8, 2007, Pages 1090-1099

  Sutton, Damon ^a,b   Wang, Shihu ^b   Nasongkla, Norased ^a,b,c   Gao, Jinming ^a   Dormidontova, Elena E ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Case Western Reserve University   (United States)

^c UCSF School of Pharmacy   (United States)

Author keywords

Drug release; Drug polymer interactions; Mathematical modeling; Physicochemical properties; Polymer micelles

Indexed keywords

BETA LAPACHONE; DOXORUBICIN; DRUG CARRIER; MACROGOL; POLY DEXTRO LACTIDE; POLYCAPROLACTONE; POLYMER; UNCLASSIFIED DRUG;

ARTICLE; DRUG BINDING; DRUG RELEASE; DRUG SOLUBILITY; DRUG STRUCTURE; HYDROPHOBICITY; MATHEMATICAL MODEL; MICELLE; PH;

DOXORUBICIN; DRUG CARRIERS; HYDROGEN-ION CONCENTRATION; HYDROPHOBICITY; KINETICS; MICELLES; MODELS, CHEMICAL; NAPHTHOQUINONES; POLYMERS;

EID: 34548462205     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0702-RM-31     Document Type: Article

References (58)

1. Soga O, van Nostrum CF, Fens M, Rijcken CJ, Schiffelers RM, Storm G, Hennink WE. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. J Control Release 103:341-353, 2005.
2. Zhang C, Ping QN, Zhang HJ. Self-assembly and characterization of paclitaxel-loaded N-octyl-O-sulfate chitosan micellar system. Colloids Surf B Biointerfaces 39:69-75, 2004.
3. Liggins RT, Burt HM. Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. Adv Drug Deliv Rev 54:191-202, 2002.
4. Zhang XC, Jackson JK, Burt HM. Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int J Pharm 132:195-206, 1996.
5. Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res 24:1-16, 2007.
6. Kwon GS. Polymeric micelles for delivery of poorly water-soluble compounds. Crit Rev Ther Drug Carrier Syst 20:357-403, 2003.
7. Sutton D, Nasongkla N, Blanco E, Gao J. Functionalized micellar systems for cancer targeted drug delivery. Pharm Res 24:1029-1046, 2007.
8. Matsumura Y, Hamaguchi T, Ura T, Muro K, Yamada Y, Shimada Y, Shirao K, Okusaka T, Ueno H, Ikeda M, Watanabe N. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer 91:1775-1781, 2004.
9. Kim TY, Kim DW, Chung JY, Shin SG, Kim SC, Heo DS, Kim NK, Bang YJ. Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clin Cancer Res 10:3708-3716, 2004.
10. Jain RK. Barriers to drug-delivery in solid tumors. Sci Am 271:58-65, 1994.
11. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK. Vascular-permeability in a human tumor xenograft: molecular-size dependence and cutoff size. Cancer Res 55:3752-3756, 1995.
12. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc Natl Acad Sci U S A 95: 4607-4612, 1998.
13. Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 73:137-172, 2001.
14. Kataoka K, Matsumoto T, Yokoyama M, Okano T, Sakurai Y, Fukushima S, Okamoto K, Kwon GS. Doxorubicin-loaded poly (ethylene glycol)-poly(beta-benzyl- l-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J Control Release 64:143-153, 2000.
15. Forrest ML, Won CY, Malick AW, Kwon GS. In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles. J Control Release 110:370-377, 2006.
16. Liu JB, Xiao YH, Allen C. Polymer-drug compatibility: A guide to the development of delivery systems for the anticancer agent, Ellipticine. J Pharm Sci 93:132-143, 2004.
17. Shuai XT, Ai H, Nasongkla N, Kim S, Gao JM. Micellar carriers based on block copolymers of poly(e-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J Control Release 98:415-426, 2004.
18. Yoo HS, Lee EA, Park TG. Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages. J Control Release 82:17-27, 2002.
19. Lee ES, Na K, Bae YH. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J Control Release 103: 405-418, 2005.
20. Fritze A, Hens F, Kimpfler A, Schubert R, Peschka-Suss R. Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient. BBA-Biomembranes 1758:1633-1640, 2006.
21. Nasongkla N, Wiedmann AF, Bruening A, Beman M, Ray D, Bornmann WG, Boothman DA, Gao JM. Enhancement of solubility and bioavailability of beta-lapachone using cyclodextrin inclusion complexes. Pharm Res 20:1626-1633, 2003.
22. Jones MC, Leroux JC. Polymeric micelles: a new generation of colloidal drug carriers. Eur J Pharm Biopharm 48:101-111, 1999.
23. Forrest ML, Zhao A, Won CY, Malick AW, Kwon GS. Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles. J Control Release 116:139-149, 2006.
24. Kang N, Perron ME, Prud'homme RE, Zhang YB, Gaucher G, Leroux JC. Stereocomplex block copolymer micelles: core-shell nanostructures with enhanced stability. Nano Lett 5:315-319, 2005.
25. Riley T, Stolnik S, Heald CR, Xiong CD, Garnett MC, Illum L, Davis SS, Purkiss SC, Barlow RJ, Gellert PR. Physicochemical evaluation of nanoparticles assembled from poly(lactic acid)-poly(ethylene glycol) (PLA-PEG) block copolymers as drug delivery vehicles. Langmuir 17: 3168-3174, 2001.
26. Engelberg I, Kohn J. Physicomechanical properties of degradable polymers used in medical applications: a comparative-study. Biomaterials 12:292-304, 1991.
27. Jamshidi K, Hyon SH, Ikada Y. Thermal characterization of polylactides. Polymer 29:2229-2234, 1988.
28. Abdekhodaie MJ, Cheng YL. Diffusional release of a dispersed solute from a spherical polymer matrix. J Membr Sci 115:171-178, 1996.
29. Baker R. Controlled Release of Biologically Active Agents. New York: John Wiley & Sons, pp39-83, 1987.
30. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 48:139-157, 2001.
31. Zhou Y, Chu JS, Wu XY. Theoretical analysis of drug release into a finite medium from sphere ensembles with various size and concentration distributions. Eur J Pharm Sci 22:251-259, 2004.
32. Grassi M, Colombo I, Lapasin R. Drug release from an ensemble of swellable crosslinked polymer particles. J Control Release 68:97-113, 2000.
33. Kiil S, Dam-Johansen K. Controlled drug delivery from swellable hydroxypropylmethylcellulose matrices: model-based analysis of observed radial front movements. J Control Release 90:1-21, 2003.
34. Higuchi T. Mechanism of sustained-action medication. J Pharm Sci 52: 1145-1149, 1963.
35. Ritger PL, Peppas NA. A simple equation for description of solute release I: Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release 5:23-36, 1987.
36. Crank J. The Mathematics of Diffusion. New York: Oxford University Press, pp89-103, 1975.
37. Lasic DD, Frederik PM, Stuart MCA, Barenholz Y, McIntosh TJ. Gelation of liposome interior: a novel method for drug encapsulation. FEBS Lett 312:255-258, 1992.
38. Sigma-Aldrich. Doxorubicin hydrochloride. In: product detail. Available at: www.sigmaaldrich.com. Accessed March 2006.
39. Devanand K, Selser JC. Asymptotic-behavior and long-range interactions in aqueous-solutions of poly(ethylene oxide). Macromolecules 24:5943-5947, 1991.
40. Siffert B, Li JF. Adsorbed polymer layer thickness determination at the solid liquid interface by different techniques. Colloids Surf 62:307-314, 1992.
41. Johnson BK, Prud'homme RK. Mechanism for rapid self-assembly of block copolymer nanoparticles. Phys Rev Let 91:1183021-1183024, 2003.
42. Crank J. The Mathematics of Diffusion. New York: Oxford University Press, p44-68, 1975.
43. Marszalek M, Bartosz M, Bartosz G. There is no evidence for the existence of complex formation between doxorubicin and glutathione. Cell Mol Biol Lett 8:311-315, 2003.
44. Cai KY, Yao KD, Lin SB, Yang ZM, Li XQ, Xie HQ, Qing TW, Gao LB. Poly(D,L-lactic acid) surfaces modified by silk fibroin: effects on the culture of osteoblast in vitro. Biomaterials 23:1153-1160, 2002.
45. Garric X, Moles JP, Garreau H, Guilhou JJ, Vert M. Human skin cell cultures onto PLA(50) (PDLLA) bioresorbable polymers: influence of chemical and morphological surface modifications. J Biomed Mater Res A 72A:180-189, 2005.
46. Tiaw KS, Goh SW, Hong M, Wang Z, Lan B, Teoh SH. Laser surface modification of poly(epsilon-caprolactone) (PCL) membrane for tissue engineering applications. Biomaterials 26:763-769, 2005.
47. Tang ZG, Black RA, Curran JM, Hunt JA, Rhodes NP, Williams DF. Surface properties and biocompatibility of solvent-cast poly[epsilon-caprolactone] films. Biomaterials 25:4741-4748, 2004.
48. Sharp JS, Forrest JA, Jones RAL. Swelling of poly(DL-lactide) and polylactide-co-glycolide in humid environments. Macromolecules 34: 8752-8760, 2001.
49. Bei JZ, Wang WH, Wang ZF, Wang SG. Surface properties and drug release behavior of polycaprolactone polyether blend and copolymer. Polym Adv Technol 7:104-107, 1996.
50. Hruby M, Konak C, Ulbrich K. Polymeric micellar pH-sensitive drug delivery system for doxorubicin. J Control Release 103:137-148, 2005.
51. Li XG, Hirsh DJ, Cabral-Lilly D, Zirkel A, Gruner SM, Janoff AS, Perkins WR. Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient. BBA-Biomembranes 1415:23-40, 1998.
52. Menozzi M, Valentini L, Vannini E, Arcamone F. Self-association of doxorubicin and related-compounds in aqueous-solution. J Pharm Sci 73:766-770, 1984.
53. Gillies ER, Frechet JMJ. pH-responsive copolymer assemblies for controlled release of doxorubicin. Bioconjug Chem 16:361-368, 2005.
54. Kitaeva MV, Melik-Nubarov NS, Menger FM, Yaroslavov AA. Doxorubicin-poly(acrylic acid) complexes: interaction with liposomes. Langmuir 20:6575-6579, 2004.
55. Missirlis D, Kawamura R, Tirelli N, Hubbell JA. Doxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticles. Eur J Pharm Sci 29:120-129, 2006.
56. Janssen MJH, Crommelin DJA, Storm G, Hulshoff A. Doxorubicin decomposition on storage: effect of pH, type of buffer and liposome encapsulation. Int J Pharm 23:1-11, 1985.
57. Impact, version 4.0. User's manual. New York: Schrödinger, LLC, 2005.
58. Soo PL, Luo LB, Maysinger D, Eisenberg A. Incorporation and release of hydrophobic probes in biocompatible polycaprolactone-block-poly (ethylene oxide) micelles: implications for drug delivery. Langmuir 18: 9996-10004, 2002.